Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) FCF Margin (2016 - 2020)

Forte Biosciences (FBRX) has disclosed FCF Margin for 5 consecutive years, with 378.97% as the latest value for Q1 2020.

  • Quarterly FCF Margin rose 19832341.0% to 378.97% in Q1 2020 from the year-ago period, while the trailing twelve-month figure was 2436.9% through Dec 2020, up 1058413.0% year-over-year, with the annual reading at 8147.22% for FY2019, 795512.0% down from the prior year.
  • FCF Margin for Q1 2020 was 378.97% at Forte Biosciences, up from 8244.44% in the prior quarter.
  • The five-year high for FCF Margin was 180144.44% in Q2 2019, with the low at 197944.44% in Q1 2019.
  • Average FCF Margin over 5 years is 38795.98%, with a median of 6544.44% recorded in 2019.
  • The sharpest move saw FCF Margin tumbled -14295521bps in 2018, then surged 30737778bps in 2019.
  • Over 5 years, FCF Margin stood at 1391.0% in 2016, then tumbled by -6531bps to 89460.0% in 2017, then crashed by -44bps to 129055.56% in 2018, then surged by 94bps to 8244.44% in 2019, then soared by 105bps to 378.97% in 2020.
  • According to Business Quant data, FCF Margin over the past three periods came in at 378.97%, 8244.44%, and 6544.44% for Q1 2020, Q4 2019, and Q3 2019 respectively.